Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancerAram F. Hezel, Andrew X. Zhu, Marcus Smith Noel et al.|British Journal of Cancer|2014Cited by 58
Paediatric oncology information pack for general practitionersJacqueline A. James, A Oakhill, M. G. Mott et al.|BMJ|1988Cited by 13